Smith & Nephew Stock Forecast, Price & News

Smith & Nephew (NYSE:SNN) Frequently Asked Questions

Is Smith & Nephew a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last twelve months. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Smith & Nephew stock.
View analyst ratings for Smith & Nephew or view top-rated stocks.

How has Smith & Nephew's stock been impacted by Coronavirus (COVID-19)?

Smith & Nephew's stock was trading at $38.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SNN shares have decreased by 16.8% and is now trading at $32.21.
View which stocks have been most impacted by COVID-19.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a drop in short interest during the month of October. As of October 29th, there was short interest totaling 677,300 shares, a drop of 23.7% from the October 14th total of 887,100 shares. Based on an average trading volume of 423,400 shares, the days-to-cover ratio is currently 1.6 days. Currently, 0.2% of the company's shares are short sold.
View Smith & Nephew's Short Interest.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) issued its quarterly earnings data on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.59.
View Smith & Nephew's earnings history.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a semi-annual dividend on Friday, August 13th. Investors of record on Friday, October 1st will be paid a dividend of $0.288 per share on Wednesday, October 27th. This represents a dividend yield of 1.9%. The ex-dividend date is Thursday, September 30th.
View Smith & Nephew's dividend history.

Is Smith & Nephew a good dividend stock?

Smith & Nephew pays an annual dividend of $0.56 per share and currently has a dividend yield of 1.74%.
View Smith & Nephew's dividend history.

What price target have analysts set for SNN?

8 brokerages have issued 12-month price objectives for Smith & Nephew's stock. Their forecasts range from $46.50 to $55.00. On average, they expect Smith & Nephew's stock price to reach $50.75 in the next year. This suggests a possible upside of 57.6% from the stock's current price.
View analysts' price targets for Smith & Nephew or view top-rated stocks among Wall Street analysts.

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the following people:

• Roland D. Diggelmann, Chief Executive Officer & Non-Executive Director
• Paul Connolly, President-Global Operations
• Anne-Francoise Nesmes, Chief Financial Officer & Executive Director
• Vasant Padmanabhan, President-Research & Development
• Catheryn O'Rourke, Chief Legal & Compliance Officer

Who are some of Smith & Nephew's key competitors?

Some companies that are related to Smith & Nephew include Align Technology (ALGN), Coloplast A/S (CLPBY), Zimmer Biomet (ZBH), STERIS (STE), Demant A/S (WILYY), Shandong Weigao Group Medical Polymer (SHWGF), Wound Management Technologies (WNDM), MSA Safety (MSA), Vicarious Surgical (RBOT), Establishment Labs (ESTA), Avanos Medical (AVNS), Inogen (INGN), Sientra (SIEN), Sanara MedTech (SMTI) and Eargo (EAR).
View all of SNN's competitors.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by many different institutional and retail investors. Top institutional investors include Cambiar Investors LLC (0.39%), Royal Bank of Canada (0.25%), Raymond James & Associates (0.17%), Prio Wealth Limited Partnership (0.14%), Credit Suisse AG (0.12%) and Goldman Sachs Group Inc. (0.11%).

Which institutional investors are selling Smith & Nephew stock?

SNN stock was sold by a variety of institutional investors in the last quarter, including Credit Suisse AG, Two Sigma Investments LP, Cambiar Investors LLC, Goldman Sachs Group Inc., Neuberger Berman Group LLC, BlackRock Inc., Comerica Bank, and Citigroup Inc..

Which institutional investors are buying Smith & Nephew stock?

SNN stock was bought by a variety of institutional investors in the last quarter, including Raymond James & Associates, Dimensional Fund Advisors LP, Royal Bank of Canada, Balyasny Asset Management LLC, Balyasny Asset Management LLC, Cinctive Capital Management LP, Point72 Asset Management L.P., and Magnetar Financial LLC.

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $32.21.

How much money does Smith & Nephew make?

Smith & Nephew has a market capitalization of $14.16 billion and generates $4.56 billion in revenue each year.

How many employees does Smith & Nephew have?

Smith & Nephew employs 18,000 workers across the globe.

When was Smith & Nephew founded?

Smith & Nephew was founded in 1856.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is www.smith-nephew.com.

Where are Smith & Nephew's headquarters?

Smith & Nephew is headquartered at BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The medical equipment provider can be reached via phone at 441923477100, via email at [email protected], or via fax at 44-20-7930-3353.